These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2503683)

  • 21. Bicarbonate exchange through the human red cell membrane determined with [14C] bicarbonate.
    Wieth JO
    J Physiol; 1979 Sep; 294():521-39. PubMed ID: 512956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton inhibition of chloride exchange: asynchrony of band 3 proton and anion transport sites?
    Milanick MA; Gunn RB
    Am J Physiol; 1986 Jun; 250(6 Pt 1):C955-69. PubMed ID: 3013020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?
    Frank RN
    Arch Ophthalmol; 1990 Sep; 108(9):1229-31. PubMed ID: 2119167
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-assisted design and synthesis of novel aldose reductase inhibitors.
    Butera J; Bagli J; Doubleday W; Humber L; Treasurywala A; Loughney D; Sestanj K; Millen J; Sredy J
    J Med Chem; 1989 Apr; 32(4):757-65. PubMed ID: 2539477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition studies on chicken muscle aldose reductase.
    Murphy DG; Davidson WS
    Biochem Pharmacol; 1985 Aug; 34(16):2961-5. PubMed ID: 3927923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site.
    Vander Jagt DL; Stangebye LA; Hunsaker LA; Eaton RP; Sibbitt WL
    Biochem Pharmacol; 1988 Mar; 37(6):1051-6. PubMed ID: 3128293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a second binding/transport site for chloride in erythrocyte anion transporter AE1 modified at glutamate 681.
    Jennings ML
    Biophys J; 2005 Apr; 88(4):2681-91. PubMed ID: 15653731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat.
    Rastelli G; Costantino L
    Bioorg Med Chem Lett; 1998 Mar; 8(6):641-6. PubMed ID: 9871575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of external chloride and DIDS binding after chemical modification of Glu-681 in human band 3.
    Bahar S; Gunter CT; Wu C; Kennedy SD; Knauf PA
    Am J Physiol; 1999 Oct; 277(4):C791-9. PubMed ID: 10516109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats.
    Notvest RR; Inserra JJ
    Diabetes; 1987 Apr; 36(4):500-4. PubMed ID: 3102300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chloride--bicarbonate exchange in red blood cells: physiology of transport and chemical modification of binding sites.
    Wieth JO; Andersen OS; Brahm J; Bjerrum PJ; Borders CL
    Philos Trans R Soc Lond B Biol Sci; 1982 Dec; 299(1097):383-99. PubMed ID: 6130537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract]   [Full Text] [Related]  

  • 35. Eosin-5-maleimide inhibits red cell Cl- exchange at a noncompetitive site that senses band 3 conformation.
    Knauf PA; Strong NM; Penikas J; Wheeler RB; Liu SQ
    Am J Physiol; 1993 May; 264(5 Pt 1):C1144-54. PubMed ID: 7684558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients.
    Ihm SH; Yoo HJ; Park SW; Park CJ
    Metabolism; 1997 Jun; 46(6):634-8. PubMed ID: 9186297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of anion transport in the red blood cell by anionic amphiphilic compounds. I. Determination of the flufenamate-binding site by proteolytic dissection of the band 3 protein.
    Cousin JL; Motais R
    Biochim Biophys Acta; 1982 May; 687(2):147-55. PubMed ID: 7046802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibition of bovine lens aldose reductase by Clinoril, its absorption into the human red cell and its effect on human red cell aldose reductase activity.
    Crabbe MJ; Freeman G; Halder AB; Bron AJ
    Ophthalmic Res; 1985; 17(2):85-9. PubMed ID: 3920599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of glucose, ouabain and an aldose reductase inhibitor on 2-[3H] myo-inositol uptake by human, rat and rabbit erythrocytes.
    Hotta N; Kakuta H; Fukasawa H; Kimura M; Koh N; Matsumae H; Fujimaki M; Sakamoto N
    Horm Metab Res; 1988 Jul; 20(7):387-90. PubMed ID: 3139540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes.
    van Griensven JM; Jusko WJ; Lemkes HH; Kroon R; Verhorst CJ; Chiang ST; Cohen AF
    Clin Pharmacol Ther; 1995 Dec; 58(6):631-40. PubMed ID: 8529328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.